Announcing our programme – ‘Raising the Bar for MS: Past, present… Future.’
The programme you’ve all been waiting for is finally here! This year, Raising the Bar for MS is focussing on looking back at where we’ve been, taking stock of our present circumstances and what we have learned in the past 6 months, and collectively reimagining a future which best meets the changing needs of those […]
MS and COVID – MSBarts survey of people with MS
The way we conduct healthcare appointments has changed drastically in the past six months since Britain entered coronavirus lockdown. Remote appointments, shared-monitoring across professionals and those living with long-term conditions, and self-monitoring or treatment are all becoming the norm. However, it has been a fast transition for all, under forced circumstances. It is essential that […]
Seeing a difference in neuromyelitis optica spectrum disorder: Integrating novel strategies into care
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Neurology Academy · ECTRIMS 2020 – Audio Summary – New Treatments For NMO Learning objectives included: Outline strategies for diagnosing NMO early and accurately how new treatments target NMO relapse phase 3 study results new treatments impacting current algorithm Kazuo Fujihara discussed early diagnosis as essential […]
Gut-CNS axis and the microbiome in MS
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Neurology Academy · ECTRIMS 2020 – Audio Summary – GutCNS in MS A collection of presentations formed this interesting session on the latest findings in the gut/central nervous system axis and the microbiome in MS. Emanuelle Waubant began the session by discussing the Microbiome in Adult […]
Closing lecture: New insights in immunopathogenesis
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Neurology Academy · ECTRIMS 2020 – Audio Summary – Immunopathogenesis Stefan Bittner closed the 8th joint ECTRIMS/ACTRIMS meeting this year, giving up to date evidence on the immunopathogenesis of MS. He began by outlining the current two-stage model of MS across early stage: the migration of […]
Hot topic – strategies for remyelination in MS
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Neurology Academy · ECTRIMS 2020 – Audio Summary – Remyelination An introduction that Jeffrey Huange gave in the final presentation sets a good scene for what we know so far which are prompting this investigation into lesion development and de/remyelination: There are insufficient oligodendrocytes despite the […]
A new treatment option for patients with relapsing forms of MS
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Neurology Academy · ECTRIMS 2020 – Audio Summary – Ozanimod Non- CME symposium hosted by Bruce Cree with presentations from Giancarlo Comi and Adil Javed examined the evidence for ozanimod which has just completed two phase 3 trials. Bruce Cree gave an overview of assessment and […]
ADIOS – adaptive ocrelizumab dosing study
Dear MS Academy Member, We are exploring a funding application to perform an Adaptive Ocrelizumab Dosing Study or ADIOS trial. The idea is to try and adjust the dosing regimen of ocrelizumab to derisk some of the emerging adverse events associated with long-term B cell depletion. Would you be interested in participating? If yes, do you mind completing the […]
Discussions in the Brain Exchange chat rooms
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Dr Agne Straukiene reported on the peer-to-peer discussion held on 12th September. Discussions were surrounded elements of care within the context of the coronavirus pandemic. Discussions in the chat rooms began around B-cell depletion therapy and whether MS services should be providing this at present. Key […]
Innovations in symptomatic and rehabilitative therapy
ECTRIMS / ACTRIMS 8th Joint Conference: MS Virtual 2020 Neurology Academy · ECTRIMS 2020 Audio Summary – Innovation in rehab The panel reviewed lifestyle, non-medical interventions and pharmacological interventions for fatigue and cognitive impairment in MS. Tiffany Braley outlined ‘Rehabilitative and Pharmacological Therapies for MS Fatigue’, examining current trends and gaps in knowledge. She highlighted […]